Literature DB >> 10629517

The effects of a modified protraction headgear on maxilla.

T Alcan1, A Keles, N Erverdi.   

Abstract

Protraction headgears are commonly used in the treatment of Class III malocclusion characterized by maxillary retrognathism. The upward and forward rotation of the maxilla during protraction is a major unwanted side effect. The aim of this study was to eliminate the upward and forward rotation of maxilla while protracting. Seventeen patients with Class III malocclusion as a result of maxillary retrognathism were treated for 3 months; their average age was 12.81 years. A full coverage acrylic cap splint-type rapid maxillary expansion appliance was cemented and activated twice a day for 5 days. After sutural separation, a maxillary modified protraction headgear was worn and 750 g of force was applied. Wilcoxon signed rank test was carried out to evaluate 42 parameters measured on cephalometric radiographs. The maxilla was displaced anteriorly by downward and backward rotation. The mandible was displaced downward and backward due to anterior elongation of the maxilla. Extrusion and lingual tipping of the upper incisors and intrusion of upper molars and downward and backward rotation of functional occlusal plane were observed. The aim of our study was achieved, which was to avoid upward and forward rotation while protracting the maxilla. In conclusion, maxillary modified protraction headgear (MMPH) can be used effectively in Class III patients with retrognathic maxilla and anterior open bite tendency.

Entities:  

Mesh:

Year:  2000        PMID: 10629517     DOI: 10.1016/s0889-5406(00)70245-9

Source DB:  PubMed          Journal:  Am J Orthod Dentofacial Orthop        ISSN: 0889-5406            Impact factor:   2.650


  9 in total

1.  Comparison of the soft and hard tissue effects of two different protraction mechanisms in class III patients: a randomized clinical trial.

Authors:  Mevlut Celikoglu; Ibrahim Yavuz; Tuba Unal; Husamettin Oktay; Abdulvahit Erdem
Journal:  Clin Oral Investig       Date:  2015-02-25       Impact factor: 3.573

2.  Alternative treatment for open bite Class III malocclusion in a child with Williams-Beuren syndrome.

Authors:  Giovanni Modesto Vieira; Eduardo Jacomino Franco; Denise Falcão Pinheiro da Rocha; Laudimar Alves de Oliveira; Rivadávio Fernandes Batista Amorim
Journal:  Dental Press J Orthod       Date:  2015 Jan-Feb

3.  Skeletal Class III malocclusion with unilateral congenitally missing maxillary incisor treated by maxillary protractor and edgewise appliances.

Authors:  Masako Tabuchi; Hayato Fukuoka; Ken Miyazawa; Shigemi Goto
Journal:  Angle Orthod       Date:  2010-03       Impact factor: 2.079

4.  Rapid maxillary expansion compared to surgery for assistance in maxillary face mask protraction.

Authors:  Nazan Küçükkeleş; Sirin Nevzatoğlu; Tamer Koldaş
Journal:  Angle Orthod       Date:  2011-01       Impact factor: 2.079

5.  Comparison of the Changes Following Two Treatment Approaches: Rapid Maxillary Expansion Versus Alternate Rapid Maxillary Expansion and Constriction.

Authors:  Fatih Çelebi; Murat Çelikdelen
Journal:  Turk J Orthod       Date:  2020-03-01

6.  Treatment of maxillary deficiency by miniplates: a case report.

Authors:  Rahman Showkatbakhsh; Abdolreza Jamilian; Mohammad Behnaz
Journal:  ISRN Surg       Date:  2011-05-10

7.  Photogrammetric Comparison of Facial Soft Tissue Profile before and after Protraction Facemask Therapy in Class III Children (6-11 Years Old).

Authors:  Vahid Moshkelgosha; Arghavan Raoof; Ahmadreza Sardarian; Parisa Salehi
Journal:  J Dent (Shiraz)       Date:  2017-03

8.  Stress on facial skin of class III subjects during maxillary protraction: a finite element analysis.

Authors:  Francesca Gazzani; Chiara Pavoni; Paola Cozza; Roberta Lione
Journal:  BMC Oral Health       Date:  2019-02-13       Impact factor: 2.757

9.  Long-term results of surgically assisted maxillary protraction vs regular facemask.

Authors:  Sirin Nevzatoğlu; Nazan Küçükkeleş
Journal:  Angle Orthod       Date:  2014-03-21       Impact factor: 2.079

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.